 |
市場調査レポート
商品コード
1441209
心臓ポンプ装置の世界市場規模、シェア、成長分析、製品タイプ別、適応症別、エンドユーザー別-産業予測、2023～2030年Global Heart Pump Device Market Size, Share, Growth Analysis, By Product Type(Ventricular assist devices, Intra-aortic balloon pumps ), By Indication(Bridge-to-transplant, Destination therapy ), By End-user - Industry Forecast 2023-2030 |
||||||
| 心臓ポンプ装置の世界市場規模、シェア、成長分析、製品タイプ別、適応症別、エンドユーザー別-産業予測、2023～2030年 |
|
出版日: 2024年02月19日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
心臓ポンプ装置の世界市場規模は2022年に20億9,000万米ドルと評価され、予測期間（2024～2031年）のCAGRは24.77%で、2023年の26億1,000万米ドルから2031年には153億2,000万米ドルに成長する展望です。
世界の心臓ポンプ装置市場は世界規模で大幅な成長を遂げています。当レポートでは、心臓ポンプ装置市場のバリューチェーン分析に関する詳細情報を網羅し、予測期間中に競争優位に立つための競合考察をメーカーに提供します。この市場成長の主要原動力は、世界規模での心血管疾患の有病率の増加です。心不全の罹患率が上昇を続ける中、重度の心疾患を持つ患者の心臓機能をサポートし維持する上で重要な役割を果たす心臓ポンプ装置の需要が大幅に増加しています。心臓疾患に罹患しやすい高齢化人口の増加が、市場の拡大にさらに寄与しています。高い疾病負担に加えて、心臓ポンプ技術の進歩も市場を前進させています。心臓ポンプ装置の小型化、耐久性の向上、機能性の強化といった技術革新は、患者の予後を大幅に改善し、採用の増加を促進しています。例えば、磁気浮上式補助人工心臓（VAD）の開拓は、合併症のリスクを低減しながら弱った心臓をより良くサポートすることで、市場に革命をもたらしました。心臓ポンプ装置市場でも、機械的循環補助装置の採用が急増しています。進行した心不全患者の増加に伴い、長期的な機械的サポートに対する需要が重要となっています。補助人工心臓（VAD）や全人工心臓（TAH）を含む機械的循環補助装置は、心臓移植を待つ患者や移植の候補として不適当と判断された患者に命綱を提供します。機械的循環補助装置が移植不適格患者の恒久的解決策となる目的地治療が受け入れられつつあることで、市場はさらに拡大しています。
目次
エグゼクティブサマリー
- 市場概要
- 転変
調査手法
- 情報調達
- セカンダリとプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
心臓ポンプ装置の世界市場：製品タイプ別
- 市場概要
- 補助心室装置（VAD）
- 大動脈内バルーンポンプ（IABP）
- 完全人工心臓（TAH）
心臓ポンプ装置の世界市場：適応症別
- 市場概要
- Bridge-to-transplant（BTT）
- デスティネーションセラピー（DT）
- Bridge to recovery（BTR）
心臓ポンプ装置の世界市場：エンドユーザー別
- 市場概要
- 病院
- 心臓病センター
- 外来手術センター
心臓ポンプ装置の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Abbott Laboratories（米国）
- Medtronic PLC（アイルランド）
- LivaNova PLC（英国）
- Berlin Heart GmbH（ドイツ）
- SynCardia Systems, LLC（米国）
- Abiomed, Inc.（米国）
- Getinge AB（スウェーデン）
- Terumo Corporation（日本）
- Teleflex Incorporated（米国）
- Jarvik Heart, Inc.（米国）
- Fresenius Medical Care AG & Co. KGaA（ドイツ）
- Calon Cardio（英国）
- CardiacAssist, Inc.（米国）
- BiVACOR Inc.（オーストラリア）
- Leviticus Cardio Ltd.（イスラエル）
- CARMAT SA（フランス）
- FineHeart SA（フランス）
- MyLVAD（米国）
- MicroPort Scientific Corporation（中国）
- TandemLife, a LivaNova company（米国）
Global Heart Pump Device Market size was valued at USD 2.09 Billion in 2022 and is poised to grow from USD 2.61 Billion in 2023 to USD 15.32 Billion by 2031, at a CAGR of 24.77% during the forecast period (2024-2031).
The global heart pump device market is witnessing substantial growth on a global scale. Our report encompasses detailed information on the value chain analysis for the Heart Pump Device market, providing manufacturers with insights to gain a competitive edge over the projected period. The primary driving force behind this market growth is the increasing prevalence of cardiovascular diseases on a global scale. As the incidence of heart failure continues to rise, the demand for heart pump devices has seen a significant upswing, given their crucial role in supporting and maintaining heart function in patients with severe cardiac conditions. The expanding aging population, more susceptible to heart ailments, further contributes to the market's expansion. In addition to the high disease burden, advancements in heart pump technology have propelled the market forward. Innovations such as miniaturization, improved durability, and enhanced functionality of heart pump devices have substantially improved patient outcomes, fostering increased adoption. For instance, the development of magnetically levitated ventricular assist devices (VADs) has revolutionized the market by providing better support to weakened hearts while reducing the risk of complications. The heart pump device market is also witnessing a surge in the adoption of mechanical circulatory support devices. With the increasing prevalence of advanced heart failure cases, the demand for long-term mechanical support has become critical. Mechanical circulatory support devices, including ventricular assist devices (VADs) and total artificial hearts (TAHs), offer a lifeline to patients awaiting heart transplantation or those deemed unsuitable candidates for transplantation. The growing acceptance of destination therapy, where mechanical circulatory support devices serve as a permanent solution for patient's ineligible for transplant, has further expanded the market's reach.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heart Pump Device Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.
Global Heart Pump Device Market Segmental Analysis
The global Heart Pump Device market can be segmented based on product type, indication, end-user, and region. Based on product type, the market can be divided into ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), total artificial heart (TAH). Based on indication, the market can be categorized into bridge-to-transplant (BTT), destination therapy (DT), bridge-to-recovery (BTR). Based on end-user, the market can be categorized into hospitals, cardiology centers, ambulatory surgical centres. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Heart Pump Device Market
Continuous innovation and ongoing advancements in heart pump technology have notably enhanced the performance and outcomes of these devices. Technological progress has given rise to the development of smaller, more durable, and more efficient heart pump devices, ultimately leading to improved patient comfort and an enhanced quality of life. A notable example is the introduction of magnetically levitated ventricular assist devices (LVADs), which has effectively reduced device-related complications and contributed to improved patient outcomes.
Restraints in the Global Heart Pump Device Market
Heart pump devices are intricate and advanced medical technologies, leading to high manufacturing and acquisition costs. The elevated expenses associated with heart pump devices present a substantial financial burden for patients, healthcare providers, and healthcare systems. Additionally, challenges arise from the limited reimbursement coverage for these devices in certain regions, creating obstacles for patients seeking access to these life-saving technologies.
Market Trends of the Global Heart Pump Device Market
Devices that are compatible with heart pump systems are engineered to work seamlessly, optimizing their performance and ensuring efficient functioning. For instance, advanced control units are capable of providing precise management of pump flow and parameters, contributing to enhanced patient outcomes. Similarly, power sources that are compatible can offer extended battery life and a reliable power supply, thereby minimizing interruptions related to the device. These compatible devices often come equipped with advanced monitoring and data management capabilities, enabling real-time remote monitoring. This capability allows healthcare professionals to track patient status and make more informed decisions.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Heart Pump Device Market by Product Type
- Market Overview
- Ventricular assist devices (VADs)
- Intra-aortic balloon pumps (IABPs)
- Total artificial heart (TAH)
Global Heart Pump Device Market by Indication
- Market Overview
- Bridge-to-transplant (BTT)
- Destination therapy (DT)
- Bridge-to-recovery (BTR)
Global Heart Pump Device Market by End-user
- Market Overview
- Hospitals
- cardiology centers
- ambulatory surgical centers
Global Heart Pump Device Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Berlin Heart GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SynCardia Systems, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abiomed, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jarvik Heart, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Calon Cardio (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CardiacAssist, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BiVACOR Inc. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Leviticus Cardio Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CARMAT SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FineHeart SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MyLVAD (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TandemLife, a LivaNova company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
